WordNet

a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery (同)Lipo-Hepin, Liquaemin
the 12th letter of the Roman alphabet (同)l

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ヘパリンおよびLMWヘパリン：用量および副作用 heparin and lmw heparin dosing and adverse effects
2. 静脈血栓塞栓症に対する低分子ヘパリン low molecular weight heparin for venous thromboembolic disease
3. 妊娠中および出産後の抗凝固薬の利用 use of anticoagulants during pregnancy and postpartum
4. 静脈血栓塞栓症：抗凝固療法の開始（開始後10日間） venous thromboembolism initiation of anticoagulation first 10 days
5. 静脈血栓塞栓症の患者における理論的根拠と無期限の抗凝固の適応 rationale and indications for indefinite anticoagulation in patients with venous thromboembolism

Profiling Analysis of Low Molecular Weight Heparins by Multiple Heart-Cutting Two Dimensional Chromatography with Quadruple Time-of-Flight Mass Spectrometry.

Ouyang Y, Zeng Y, Rong Y, Song Y, Shi L, Chen B, Yang X, Xu N, Linhardt RJ, Zhang Z.
Analytical chemistry.Anal Chem.2015 Jul 29. [Epub ahead of print]
Low molecular weight heparins (LMWHs) are polydisperse and microheterogenous mixtures of polysaccharides used as anticoagulant drugs. Profiling analysis is important for obtaining deeper insights into the structure of LMWHs. Previous oligosaccharide mapping methods are relatively low resolution and
PMID 26222954

Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.

Wang C1, Zhai Z, Yang Y, Cheng Z, Ying K, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH, Davidson BL; China National Venous Thromboembolism (VTE) Study Group.
The clinical respiratory journal.Clin Respir J.2015 Jan 26. doi: 10.1111/crj.12262. [Epub ahead of print]
INTRODUCTION: Clinically relevant bleeding occurs three times as frequently as recurrent venous thromboembolism in the modern early treatment of pulmonary embolism (PE) with fixed-dose, unmonitored anticoagulants. Unfractionated heparin (UFH) is monitored and adjusted to assure efficacy and minimize
PMID 25619125

Effect of switching unfractionated heparin to low-molecular-weight heparin on serum potassium in hemodialysis patients.

Ezzatzadegan Jahromi S, Mahmoodi MS, Behroozi F, Roozbeh J1, Emamghoreishi F.
Iranian journal of kidney diseases.Iran J Kidney Dis.2014 Nov;8(6):475-80.
INTRODUCTION: Unfractionated (UF) heparin is the most common anticoagulant used during hemodialysis. Failure of the kidneys to excrete potassium as well as heparin-induced reduction of aldosterone synthesis put hemodialysis patients at risk of hyperkalemia. It has not yet been clearly known whether
PMID 25362223

High-Throughput Turbidimetric Screening for Heparin-Neutralizing Agents and Low-Molecular-Weight Heparin Mimetics

Sekiya Atsushi,Oishi Shinya,Fujii Nobutaka [他],Koide Takaki
Chemical and Pharmaceutical Bulletin 60(3), 371-376, 2012
… Safer heparin-neutralizing agents are currently required to replace protamine, the use of which causes adverse effects such as anaphylaxia. … Low-molecular-weight (LMW) heparin mimetics that potentiate antithrombin III (AT) action are also valuable as anti-thrombotics. … This paper describes a high-throughput assay for both heparin-neutralizing agents and LMW heparin mimetics without the use of blood preparations. …
NAID 130001852423

英: low-molecular-weight heparin low molecular weight heparin LMW heparin LMWH
同: 低分子量ヘパリン
関: 未分画ヘパリン、ヘパリン、血液凝固因子

低分子ヘパリン : 約 11,600 件
低分子量ヘパリン : 約 62,700 件

リンク元	「低分子量ヘパリン」
関連記事	「LM」「L」